[1]
Rawson, N.S.B. 2020. Alignment of health technology assessments and price negotiations for new drugs for rare disorders in Canada: Does it lead to improved patient access?. Journal of Population Therapeutics and Clinical Pharmacology. 27, 1 (Feb. 2020), e48-e64. DOI:https://doi.org/10.15586/jptcp.v27i1.658.